{"article":{"annotation":{"article_id":"ema-prac-october-2026-pharmacovigilance-outcomes","available_at":"2026-10-12T09:41:45.342573Z","geography_revision":"ef6ee0010dda5fe7b240fd514749b43e214c57da73222d2e40ec83b276dd0977","id":"360f1a7e38b1ffd63f964c457f1b37aad76751aca0826ffe31110b3e43e9287b","input_sha256":"67fe6f7519bf041750c9f6477bf1f919fdadb2040ea2111e73f5a89945120c52","limitations":["Rule-derived subjects are candidates, not verified editorial labels or calibrated model probabilities.","Coverage is distinct from event location. Unknown country/city/coordinates remain absent; no automatic geocoding.","Article geometries keep their stated precision and methodology; reproducing them is not independent coordinate verification."],"method":"controlled-rules-v1","places":[],"rules_sha256":"fb5ad3c27c91cb840f7a0a05f7f64a5cb26ad0374409ff9457f277c7092e22b4","schema_version":1,"subjects":[{"concept_id":"medtop:07000000","confidence":null,"confidence_method":null,"evidence":[{"field":"category+topics","language":"en","note":"Preserved editorial category/topic; broad candidate only","source_urls":["https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-28-september-1-october","https://www.ema.europa.eu/no/committees/pharmacovigilance-risk-assessment-committee-prac"]}],"method":"controlled-rules-v1","rule_id":"health-broad","status":"candidate"}],"taxonomy_revision":"1f2db31d811fca07e99b16d402c10e2cc2965c9df1c7b41d9be348b40a24e7fb","taxonomy_version":"IPTC Media Topics 2026-Q2"},"api_url":"https://newsverum.com/api/v1/articles/ema-prac-october-2026-pharmacovigilance-outcomes?lang=fr","category":"health","content":{"key_points":[],"paragraphs":["Le comité d’évaluation des risques en matière de pharmacovigilance (PRAC) de l’Agence européenne des médicaments a publié les chiffres d’octobre après sa réunion du 28 septembre au 1er octobre. Le bilan recense 85 évaluations uniques de rapports périodiques actualisés de sécurité, 49 plans de gestion des risques pour des médicaments autorisés de manière centralisée et 16 études post-autorisation.","Le comité a signalé neuf signaux de sécurité : cinq ont été lancés et quatre étaient en cours ou conclus. L’EMA indique qu’aucune procédure de saisine n’a été commencée ou conclue pendant la réunion. Ces nombres ne démontrent pas qu’un médicament a causé un dommage ni qu’une nouvelle restriction a été imposée.","L’agence précise que les statistiques reposent sur le projet d’ordre du jour. Un signal peut indiquer une association entre un médicament et un événement qui mérite une enquête ; il ne prouve pas à lui seul la causalité."],"sections":[]},"corrections":[{"at":"2026-10-07T00:56:16+03:00","language":"fr","text":"Des éditions allemande et portugaise, ainsi que les traductions des explications des données et des corrections, ont été ajoutées à cet article."},{"at":"2026-10-12T06:19:32+03:00","language":"fr","text":"La formulation des traductions des libellés ou des explications des données a été corrigée."}],"country":null,"data":{"blocks":[{"description":{"ar":"أعداد التقييمات الشهرية استناداً إلى جدول الأعمال الأولي.","de":"Monatliche Bewertungszahlen auf Grundlage des Entwurfs der Tagesordnung.","en":"Monthly assessment counts based on the draft agenda.","es":"Recuentos mensuales de evaluaciones según el proyecto de orden del día.","fr":"Nombre mensuel d’évaluations selon le projet d’ordre du jour.","pt":"Contagens mensais de avaliações com base na pauta preliminar.","tr":"Taslak gündeme dayalı aylık değerlendirme sayıları."},"id":"verified-indicators","items":[{"basis":"observed","label":{"ar":"إشارات السلامة","de":"Sicherheitssignale","en":"Safety signals","es":"Señales de seguridad","fr":"Signaux de sécurité","pt":"Sinais de segurança","tr":"Güvenlik sinyalleri"},"measure":{"aggregation":"flow","frequency":"monthly","geography":"european-union","id":"prac-safety-signals","periodRole":"announcement-date","unitCode":"count"},"period":"2026-10","unit":"count","value":9},{"basis":"observed","label":{"ar":"التقييمات المنفردة لتقارير PSUR","de":"Einzelbewertungen von PSUR","en":"PSUR single assessments","es":"Evaluaciones únicas de PSUR","fr":"Évaluations uniques de PSUR","pt":"Avaliações individuais de PSUR","tr":"PSUR tekil değerlendirmeleri"},"measure":{"aggregation":"flow","frequency":"monthly","geography":"european-union","id":"prac-psur-single-assessments","periodRole":"announcement-date","unitCode":"count"},"period":"2026-10","unit":"count","value":85},{"basis":"observed","label":{"ar":"خطط إدارة مخاطر الأدوية المرخصة مركزياً","de":"Risikomanagementpläne für zentral zugelassene Arzneimittel","en":"Risk-management plans for centrally authorised medicines","es":"Planes de gestión de riesgos para medicamentos autorizados mediante procedimiento centralizado","fr":"Plans de gestion des risques pour les médicaments autorisés par procédure centralisée","pt":"Planos de gerenciamento de riscos para medicamentos autorizados por procedimento centralizado","tr":"Merkezi ruhsatlı ilaçlar için risk yönetim planları"},"measure":{"aggregation":"flow","frequency":"monthly","geography":"european-union","id":"prac-central-risk-plans","periodRole":"announcement-date","unitCode":"count"},"period":"2026-10","unit":"count","value":49},{"basis":"observed","label":{"ar":"دراسات السلامة بعد الترخيص","de":"Sicherheitsstudien nach der Zulassung","en":"Post-authorisation safety studies","es":"Estudios de seguridad posteriores a la autorización","fr":"Études de sécurité post-autorisation","pt":"Estudos de segurança pós-autorização","tr":"Ruhsat sonrası güvenlilik çalışmaları"},"measure":{"aggregation":"flow","frequency":"monthly","geography":"european-union","id":"prac-post-authorisation-safety-studies","periodRole":"announcement-date","unitCode":"count"},"period":"2026-10","unit":"count","value":16},{"basis":"observed","label":{"ar":"إجراءات الإحالة التي بدأت أو استمرت أو اختُتمت","de":"Begonnene, laufende oder abgeschlossene Befassungsverfahren","en":"Referrals started, ongoing or concluded","es":"Remisiones iniciadas, en curso o concluidas","fr":"Saisines commencées, en cours ou conclues","pt":"Procedimentos de encaminhamento iniciados, em andamento ou concluídos","tr":"Başlatılan, süren veya sonuçlanan sevk prosedürleri"},"measure":{"aggregation":"flow","frequency":"monthly","geography":"european-union","id":"prac-referral-procedures","periodRole":"announcement-date","unitCode":"count"},"period":"2026-10","unit":"count","value":0}],"methodology":{"ar":"إشارة السلامة ليست دليلاً على السببية؛ وجميع الأعداد مبنية على جدول الأعمال الأولي.","de":"Ein Sicherheitssignal beweist keine Ursache; alle Zahlen beruhen auf dem Entwurf der Tagesordnung.","en":"A safety signal is not proof of causation; all counts are based on the draft agenda.","es":"Una señal de seguridad no prueba causalidad; todos los recuentos se basan en el proyecto del orden del día.","fr":"Un signal de sécurité ne prouve pas la causalité ; tous les chiffres reposent sur le projet d’ordre du jour.","pt":"Um sinal de segurança não comprova causalidade; todas as contagens se baseiam na pauta preliminar.","tr":"Güvenlik sinyali nedensellik kanıtı değildir; tüm sayılar taslak gündem temellidir."},"sourceUrls":["https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-28-september-1-october"],"title":{"ar":"إحصاءات لجنة PRAC في أكتوبر","de":"PRAC-Statistik für Oktober","en":"PRAC October statistics","es":"Estadísticas de octubre del PRAC","fr":"Statistiques d’octobre du PRAC","pt":"Estatísticas do PRAC em outubro","tr":"PRAC ekim istatistikleri"},"type":"metrics","updatedAt":"2026-10-12T06:19:32+03:00"}],"version":1},"data_downloads":[{"formats":{"csv":"https://newsverum.com/api/v1/articles/ema-prac-october-2026-pharmacovigilance-outcomes/data/verified-indicators?lang=fr&format=csv","json":"https://newsverum.com/api/v1/articles/ema-prac-october-2026-pharmacovigilance-outcomes/data/verified-indicators?lang=fr&format=json"},"id":"verified-indicators"}],"data_types":["metrics"],"editorial_illustration":{"alt":"Illustration conceptuelle de la santé publique, de la recherche et des données connectées.","asset_id":"newsverum-v1-health","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.avif","width":1536}],"caption":null,"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"fr","scope":"topic","url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","width":1536}],"width":1536},"event_id":"event-4e22bbce-1bd4-5a4f-adf7-eedfd2dca91c","event_period":"2026-10-02","event_period_basis":"event-or-reference-period","id":"ema-prac-october-2026-pharmacovigilance-outcomes","image":null,"importance":0.6,"language":"fr","modified_at":"2026-10-12T06:19:32+03:00","publication_basis":"publication-record","published_at":"2026-10-04T01:05:40+00:00","reading_minutes":2,"region":"world","relations":[],"section_illustration":{"alt":"Illustration conceptuelle de la santé publique, de la recherche et des données connectées.","asset_id":"newsverum-v1-health","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.avif","width":1536}],"caption":null,"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"fr","scope":"section","url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","width":1536}],"width":1536},"slug":"ema-prac-october-2026-pharmacovigilance-outcomes","sources":[{"checkedAt":"2026-10-04","name":"European Medicines Agency","publishedAt":"2026-10-02","url":"https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-28-september-1-october"},{"checkedAt":"2026-10-04","name":"European Medicines Agency PRAC committee calendar","url":"https://www.ema.europa.eu/no/committees/pharmacovigilance-risk-assessment-committee-prac"}],"summary":"Les chiffres mensuels du PRAC recensent neuf signaux de sécurité, 49 plans de gestion des risques et 16 études post-autorisation.","text":"Les chiffres mensuels du PRAC recensent neuf signaux de sécurité, 49 plans de gestion des risques et 16 études post-autorisation.\n\nLe comité d’évaluation des risques en matière de pharmacovigilance (PRAC) de l’Agence européenne des médicaments a publié les chiffres d’octobre après sa réunion du 28 septembre au 1er octobre. Le bilan recense 85 évaluations uniques de rapports périodiques actualisés de sécurité, 49 plans de gestion des risques pour des médicaments autorisés de manière centralisée et 16 études post-autorisation.\n\nLe comité a signalé neuf signaux de sécurité : cinq ont été lancés et quatre étaient en cours ou conclus. L’EMA indique qu’aucune procédure de saisine n’a été commencée ou conclue pendant la réunion. Ces nombres ne démontrent pas qu’un médicament a causé un dommage ni qu’une nouvelle restriction a été imposée.\n\nL’agence précise que les statistiques reposent sur le projet d’ordre du jour. Un signal peut indiquer une association entre un médicament et un événement qui mérite une enquête ; il ne prouve pas à lui seul la causalité.\n\nDes éditions allemande et portugaise, ainsi que les traductions des explications des données et des corrections, ont été ajoutées à cet article.\n\nLa formulation des traductions des libellés ou des explications des données a été corrigée.","title":"Le comité de sécurité de l’EMA a évalué 85 rapports de médicaments en octobre","topics":[],"translations":[{"api_url":"https://newsverum.com/api/v1/articles/ema-prac-october-2026-pharmacovigilance-outcomes?lang=tr","language":"tr","url":"https://newsverum.com/tr/news/ema-prac-october-2026-pharmacovigilance-outcomes"},{"api_url":"https://newsverum.com/api/v1/articles/ema-prac-october-2026-pharmacovigilance-outcomes?lang=en","language":"en","url":"https://newsverum.com/en/news/ema-prac-october-2026-pharmacovigilance-outcomes"},{"api_url":"https://newsverum.com/api/v1/articles/ema-prac-october-2026-pharmacovigilance-outcomes?lang=ar","language":"ar","url":"https://newsverum.com/ar/news/ema-prac-october-2026-pharmacovigilance-outcomes"},{"api_url":"https://newsverum.com/api/v1/articles/ema-prac-october-2026-pharmacovigilance-outcomes?lang=fr","language":"fr","url":"https://newsverum.com/fr/news/ema-prac-october-2026-pharmacovigilance-outcomes"},{"api_url":"https://newsverum.com/api/v1/articles/ema-prac-october-2026-pharmacovigilance-outcomes?lang=es","language":"es","url":"https://newsverum.com/es/news/ema-prac-october-2026-pharmacovigilance-outcomes"},{"api_url":"https://newsverum.com/api/v1/articles/ema-prac-october-2026-pharmacovigilance-outcomes?lang=de","language":"de","url":"https://newsverum.com/de/news/ema-prac-october-2026-pharmacovigilance-outcomes"},{"api_url":"https://newsverum.com/api/v1/articles/ema-prac-october-2026-pharmacovigilance-outcomes?lang=pt","language":"pt","url":"https://newsverum.com/pt/news/ema-prac-october-2026-pharmacovigilance-outcomes"}],"url":"https://newsverum.com/fr/news/ema-prac-october-2026-pharmacovigilance-outcomes"},"version":"1"}
